Company facts
- Entity structure
- Other
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The University Of Chicago | R37CA272755 | $320,809 | |
| The University Of Chicago | U01NS131797 | $105,363 | |
| University Of Miami | U19HD119884 | $59,470 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | R01AI187016 | $100,901 | |
| University Of Miami | U54CA302465 | $74,949 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Emory University operates as a federal grant recipient and sub-recipient, conducting biomedical research funded primarily by the National Institutes of Health and the Centers for Disease Control and Prevention. The university holds 14 prime grants (74% of recent awards) and participates as a sub-recipient on 5 grants (26%), with a nineteen-award footprint spanning infectious disease, oncology, cardiopulmonary, metabolic, and environmental health research.
Emory's customer concentration is dominated by the Department of Health and Human Services. The top five HHS institutes and offices account for 63% of awards by count and 72% by combined potential value, led by the CDC's Office of Acquisition Services (7 awards, $508 thousand combined potential value). The NIH's National Institute of Allergy and Infectious Diseases (2 awards), National Cancer Institute, National Heart Lung and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Environmental Health Sciences collectively round out the active grantor set. Emory's grant work concentrates in scientific and technical consulting (5 awards) and analytical laboratory instrument and medical supply categories (3 awards by PSC code).
Recent representative grants include sub-awards as a sub-recipient: an October 2025 sub-grant from the University of Miami (Principal Grantee) for STAR2-ASSIST vaccine research; a September 2025 sub-award from the University of Pittsburgh for HIV vaccine efficacy work leveraging CD4 T follicular helper 1 cell mechanisms; and a September 2025 U54 SPORE sub-award from Miami focused on cancer prevention and research. Emory also received a December 2024 pharmacological R03 sub-grant and an April 2023 real-time risk prognostication sub-award, both through the University of Miami as lead grantee.
Activity is sparse but concentrated in the recent period — awards skipped from 2013 to 2023, then resumed with one award in both 2023 and 2024, and three in 2025. The combined potential value across nineteen awards totals $715 thousand, though obligated dollars reach $1.1 million, indicating earlier-phase grants have since matured into formal obligation cycles. Emory holds no contract vehicles or contract prime awards; its federal footprint is exclusively grant-focused research administration and execution.
Quick answers
Is Emory University registered in SAM.gov?
Emory University's SAM.gov registration expired on April 3, 2013.
What is Emory University's most recent federal award?
Emory University's most recent federal contract award is Blood supply (HHSD20020130655P), from CDC Office of Acquisition Services, on April 3, 2013.
On GovTribe
See Emory University's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors